Literature DB >> 3114009

Ovarian follicular development in oral contraceptive cycles.

S Killick, E Eyong, M Elstein.   

Abstract

The cyclic changes in serum hormone concentrations, ovarian follicular development, uterine size, and endometrial appearance have been observed in 58 spontaneous ovulatory cycles and compared with 22 initial cycles of oral contraceptive (OC) therapy. A far greater inhibitory effect on the ovary was achieved by starting contraception on day 1 of the cycle rather than on day 5. The relevance of these findings with regard to OC failures is discussed.

Mesh:

Substances:

Year:  1987        PMID: 3114009     DOI: 10.1016/s0015-0282(16)59407-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Frequency and treatment of ovarian cysts in adolescence.

Authors:  E Porcu; S Venturoli; L Dal Prato; R Fabbri; R Paradisi; C Flamigni
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

Review 2.  Hormone response in ovarian cancer: time to reconsider as a clinical target?

Authors:  Francesmary Modugno; Robin Laskey; Ashlee L Smith; Courtney L Andersen; Paul Haluska; Steffi Oesterreich
Journal:  Endocr Relat Cancer       Date:  2012-11-09       Impact factor: 5.678

Review 3.  Ovarian follicular development during the use of oral contraception: a review.

Authors:  Angela R Baerwald; Roger A Pierson
Journal:  J Obstet Gynaecol Can       Date:  2004-01

4.  Ultrasound image attributes of human ovarian dominant follicles during natural and oral contraceptive cycles.

Authors:  Rebecca L Birtch; Angela R Baerwald; Olufemi A Olatunbosun; Roger A Pierson
Journal:  Reprod Biol Endocrinol       Date:  2005-04-13       Impact factor: 5.211

5.  Effects of oral contraceptive pills on mood and magnetic resonance imaging measures of prefrontal cortical thickness.

Authors:  Nicole Petersen; Nicholas W Kearley; Dara G Ghahremani; Jean-Baptiste Pochon; Megan E Fry; Andrea J Rapkin; Edythe D London
Journal:  Mol Psychiatry       Date:  2021-01-08       Impact factor: 15.992

6.  DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk.

Authors:  Dominique Bernard-Gallon; Rémy Bosviel; Laetitia Delort; Luc Fontana; Alain Chamoux; Nadège Rabiau; Fabrice Kwiatkowski; Nasséra Chalabi; Samir Satih; Yves-Jean Bignon
Journal:  Mol Cancer       Date:  2008-05-02       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.